Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Financial Results:
Camlin Fine Sciences Ltd reported Revenues for Q2FY25 of ₹423.00 Crores up from ₹406.00 Crore year on year, a rise of 4.19%.
Total Expenses for Q2FY25 of ₹427.00 Crores up from ₹420.00 Crores year on year, a rise of 1.67%.
Consolidated Net Profit of -₹116.00 Crores from -₹21.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹5.33, from -₹1.03 in the same quarter of the previous year.